Home » Authors » James Etheridge

Articles by James Etheridge

Vivalis Completes EUR3M Initial Round For Transgenics Work

Feb. 12, 2003

By James Etheridge

Entomed Appoints New CEO, Advances Discovery Programs

Feb. 12, 2003

By James Etheridge

Transgene Reports Successful Results From Adenoviral Vector

Feb. 12, 2003

By James Etheridge

Vivalis Completes EUR3M Initial Round For Transgenics Work

Feb. 12, 2003

By James Etheridge

Entomed Appoints New CEO, Advances Discovery Programs

Feb. 12, 2003

By James Etheridge

Transgene Reports Successful Results From Adenoviral Vector

Feb. 12, 2003

By James Etheridge

Serono, Genentech Extend Marketing Deal For Raptiva

Feb. 12, 2003

By James Etheridge

NicOx, Biolipox Expand Alliance To Areas Of Inflammation, Pain

Feb. 5, 2003

By James Etheridge

Rebif Sales Help Push Serono Over $1.5B In 2002 Revenues

Feb. 5, 2003

By James Etheridge

Transgene Licenses Technology To Merck On Nonexclusive Basis

Feb. 5, 2003

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...